Your browser doesn't support javascript.
loading
Structural basis for recognition of 26RFa by the pyroglutamylated RFamide peptide receptor.
Jin, Sanshan; Guo, Shimeng; Xu, Youwei; Li, Xin; Wu, Canrong; He, Xinheng; Pan, Benxun; Xin, Wenwen; Zhang, Heng; Hu, Wen; Yin, Yuling; Zhang, Tianwei; Wu, Kai; Yuan, Qingning; Xu, H Eric; Xie, Xin; Jiang, Yi.
Affiliation
  • Jin S; Lingang Laboratory, Shanghai, China.
  • Guo S; State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.
  • Xu Y; State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.
  • Li X; State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.
  • Wu C; University of Chinese Academy of Sciences, Beijing, China.
  • He X; State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.
  • Pan B; State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.
  • Xin W; University of Chinese Academy of Sciences, Beijing, China.
  • Zhang H; Lingang Laboratory, Shanghai, China.
  • Hu W; State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.
  • Yin Y; University of Chinese Academy of Sciences, Beijing, China.
  • Zhang T; School of Pharmaceutical Science and Technology, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences, Hangzhou, Zhejiang, China.
  • Wu K; State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.
  • Yuan Q; State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.
  • Xu HE; The Shanghai Advanced Electron Microscope Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.
  • Xie X; Lingang Laboratory, Shanghai, China.
  • Jiang Y; Lingang Laboratory, Shanghai, China.
Cell Discov ; 10(1): 58, 2024 Jun 04.
Article in En | MEDLINE | ID: mdl-38830850
ABSTRACT
The neuropeptide 26RFa, a member of the RF-amide peptide family, activates the pyroglutamylated RF-amide peptide receptor (QRFPR), a class A GPCR. The 26RFa/QRFPR system plays critical roles in energy homeostasis, making QRFPR an attractive drug target for treating obesity, diabetes, and eating disorders. However, the lack of structural information has hindered our understanding of the peptide recognition and regulatory mechanism of QRFPR, impeding drug design efforts. In this study, we determined the cryo-EM structure of the Gq-coupled QRFPR bound to 26RFa. The structure reveals a unique assembly mode of the extracellular region of the receptor and the N-terminus of the peptide, and elucidates the recognition mechanism of the C-terminal heptapeptide of 26RFa by the transmembrane binding pocket of QRFPR. The study also clarifies the similarities and distinctions in the binding pattern of the RF-amide moiety in five RF-amide peptides and the RY-amide segment in neuropeptide Y. These findings deepen our understanding of the RF-amide peptide recognition, aiding in the rational design of drugs targeting QRFPR and other RF-amide peptide receptors.

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Cell Discov Year: 2024 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Cell Discov Year: 2024 Document type: Article Affiliation country:
...